spacer
home > pmps > summer 2017 > track your progress
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Track Your Progress

While serialisation in the pharmaceutical supply chain is generally regarded as inevitable – counterfeiting is simply too large of a problem to not be addressed – some uncertainty around the specifics exists, particularly from a global position. Regulations are advancing at various speeds around the world, and, to date, global standards as to how serial numbers should be formatted have not emerged.

Progressing Through Uncertainty

This has demanded that manufacturers move forward cautiously in their approach to serialisation. They must take steps to prepare without committing themselves to technologies that may not support future requirements. To that end, many have placed systems necessary to apply and capture serialisation data in their packaging processes, but have, in general, not addressed the impact of tracking these numbers across the supply chain.

This is partly due to the nature of a typical pharma supply chain, which is more dependent on third-party logistics providers for downstream processes than other industries. These providers enable companies to minimise supply chain assets and focus their capital on R&D, but they tend to limit their investments in automation because short-term contracts do not allow a return on investment within the contract period.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Michiel Veenman, Global Market Leader at Swisslog Warehouse and Distribution Solutions, has worked with various pharma companies to design advanced intralogistics solutions prior to taking on his current role. As such, he is responsible for continuously improving the company’s contribution to the market. This includes market research, organisational development and training and solution design, as well as systems support. Having studied logistics, Michiel has experience working for the Dutch Department of Defense and in automation system simulation and analysis. Before joining Swisslog, he spent five years optimising warehouse operations and IT systems for a small veterinarian pharma wholesaler.
spacer
Michiel Veenman
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

BBI Solutions broadens antibody portfolio and strengthens reagent technical support capabilities with acquisition of Maine Biotechnology Services

BBI, a leading manufacturer of raw materials and finished test platforms, already provides human antigens, antibodies, serum and plasma products and clinical chemistry enzymes, for the in-vitro diagnostics market. Now with the acquisition of MBS they have strengthened their antibody offering, providing a comprehensive portfolio and custom services to deliver a total reagent solution for any immunoassay development.
More info >>

White Papers

The Importance of Critical Temperatures in the Freeze Drying of Pharmaceutical Products

Biopharma Group

Every formulation has a critical temperature, below which it should be cooled for complete solidification and maintained below during primary drying in order to prevent processing defects. To design a freeze drying cycle on a rational basis such information should be identified.
More info >>

 
Industry Events

13th Annual Biomarkers Congress

15-16 February 2018, Manchester Central Convention Complex, Manchester, UK

Oxford Global is proud to present the 13th Annual Biomarkers Congress to be held on 15-16 February 2018, Manchester. The congress covers novel developments in biomarker discovery and validation, translation into the clinic, personalised healthcare, Big data management, clinical diagnostics development. Key therapeutic focus areas include Immuno Oncology, Neuroscience, Respiratory, Metabolic and Cardiovascular Diseases
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement